NDC 50090-6034-01 - Lisinopril and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6034
- Requested NDC
- 50090-6034-01
- Package NDCs from labels
- 50090-6034-1, 50090-6034-2, 50090-6034-0, 50090-6034-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-01-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lisinopril and Hydrochlorothiazide Tablets - A-S Medication Solutions | A-S Medication Solutions | 2026-01-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6034-0 | Lisinopril and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | 8 | |
| 50090-6034-1 | Lisinopril and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 8 | |
| 50090-6034-2 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET | 90 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6034 | LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS) TABLET [A-S MEDICATION SOLUTIONS] | 6 | Current NDC, Legacy NDC, 3 package rows | 20241017_22036b58-c1fe-45b5-ae08-93fdaf716528.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6034-0 | EA - Each | 50090-6034 | 768c8083-6d51-4dae-bf68-f4fa1af6af99 | 1 | 2022-08-04 |
| 50090-6034-1 | EA - Each | 50090-6034 | 62afcf9a-5221-4ad5-b57f-77fcad61cf0b | 1 | 2022-08-04 |
| 50090-6034-2 | EA - Each | 50090-6034 | 8fa2d4b5-d6b2-4c89-8d15-59d0a6ea8496 | 1 | 2022-08-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Westminster Pharmaceuticals, LLC | 0fc94bc2-fa38-439a-a609-1b4130cdacb1 | 2026-09-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Topco Associates LLC | af314adb-bd65-4233-b7e1-6cfb819615a3 | 2026-09-25 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO-TOUCH | Walgreens Company | 33219878-f102-46c6-bd63-e83d54fa2785 | 2026-09-25 | Warnings | 1K09F3G675 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Ascend Laboratories, LLC | 798fee33-51ad-45d0-82f3-09289304139f | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | b9b85048-5776-455f-bea6-6ab818cb8144 | 2026-09-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 2dd7c2a4-d335-4c6f-b1e6-b0ae6eebab84 | 2026-09-23 | Warnings, Adverse reactions | 0J48LPH2TH |
| Calamine | CALAMINE, PRAMOXIND HCL | Nice-Pak Products, LLC | 9089e23e-ca4a-454f-8dcc-ff5a29a5a335 | 2026-09-22 | Warnings, Adverse reactions | 1K09F3G675 |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | e92f1118-8eaf-4fa8-b167-1447550af1ab | 2026-09-18 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 2db1a899-f115-4da5-89fe-6e5b41086f6c | 2026-09-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | 5ba10848-9a4c-1a28-e063-6394a90ab047 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 5ba2325f-5fc1-f6f0-e063-6294a90aefc6 | 2026-09-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| Metoprolol Tartrate and Hydrochlorothiazide | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | b6cf0f43-8dc3-4535-b651-daf1f9e0336c | 2026-09-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| Calamine | CALAMINE, ZINC OXIDE | Nice-Pak Products, LLC | c370ee1f-1887-44e8-8d47-8ffa3c270ff5 | 2026-09-15 | Warnings, Adverse reactions | 1K09F3G675 |
| lisinopril | LISINOPRIL | REMEDYREPACK INC. | c57e8bc8-ff50-431e-9c1a-384503584d02 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | REMEDYREPACK INC. | d383e0e5-4e00-44cc-9d6f-86e76f4e79e3 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | ANDA076230 197885 E7199S1YWR 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 206cd386-cf38-4e0f-80ec-685aea41b048 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 1fad059f-f030-4dd8-b02a-bf3e775d37d2 | 2026-09-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan medoxomil and hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 20a76be4-05c1-4df3-96ae-cb9f7f3dfe09 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | PD-Rx Pharmaceuticals, Inc. | 9470b102-3c81-469a-a4c5-6816d9d39b07 | 2026-09-14 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Spironolactone and hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Advagen Pharma Ltd. | 9c6c8815-50d8-4a3c-b348-98d5084c1408 | 2026-09-11 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.